1. Home
  2. HWKN vs VKTX Comparison

HWKN vs VKTX Comparison

Compare HWKN & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hawkins Inc.

HWKN

Hawkins Inc.

HOLD

Current Price

$132.19

Market Cap

3.4B

ML Signal

HOLD

Logo Viking Therapeutics Inc.

VKTX

Viking Therapeutics Inc.

HOLD

Current Price

$38.19

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HWKN
VKTX
Founded
1938
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.3B
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
HWKN
VKTX
Price
$132.19
$38.19
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$200.00
$95.86
AVG Volume (30 Days)
178.8K
3.1M
Earning Date
05-13-2026
04-29-2026
Dividend Yield
0.46%
N/A
EPS Growth
N/A
N/A
EPS
3.91
N/A
Revenue
$1,083,696,000.00
N/A
Revenue This Year
$12.37
N/A
Revenue Next Year
$6.30
N/A
P/E Ratio
$34.21
N/A
Revenue Growth
11.21
N/A
52 Week Low
$117.98
$22.96
52 Week High
$186.15
$43.15

Technical Indicators

Market Signals
Indicator
HWKN
VKTX
Relative Strength Index (RSI) 28.33 57.97
Support Level $128.75 $29.10
Resistance Level $156.86 $39.78
Average True Range (ATR) 7.35 2.67
MACD -1.97 0.16
Stochastic Oscillator 4.61 60.17

Price Performance

Historical Comparison
HWKN
VKTX

About HWKN Hawkins Inc.

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: